失败的教训——为未来的HIV-1疫苗效力试验做准备 - Suppr

Suppr

超能文献

Lessons from failure--preparing for future HIV-1 vaccine efficacy trials.

作者信息

Graham Barney S, Mascola John R

出版信息

J Infect Dis. 2005 Mar 1;191(5):647-9. doi: 10.1086/428406. Epub 2005 Jan 27.

DOI:10.1086/428406

PMID:15688276

Abstract

摘要

相似文献

Lessons from failure--preparing for future HIV-1 vaccine efficacy trials.

J Infect Dis. 2005 Mar 1;191(5):647-9. doi: 10.1086/428406. Epub 2005 Jan 27.

Controversial HIV vaccine enters phase III trials amid skepticism.

AIDS Alert. 1998 Dec;13(12):133-4, 136.

Public health. A sound rationale needed for phase III HIV-1 vaccine trials.

Science. 2004 Jan 16;303(5656):316. doi: 10.1126/science.1094620.

Funding support lacking in search for HIV vaccine.

AIDS Alert. 1999 Jan;14(1):5-7.

Vaccine to prevent AIDS overstated.

Res Initiat Treat Action. 1999 Jan;5(1):11-2.

AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.

Science. 2004 Jun 25;304(5679):1913-4. doi: 10.1126/science.1100368.

HIV vaccine efficacy trials: towards the future of HIV prevention.

Infect Dis Clin North Am. 2007 Mar;21(1):201-17, x. doi: 10.1016/j.idc.2007.01.006.

AIDS vaccine: efficacy, safety and ethics.

Vaccine. 2008 Jun 6;26(24):3072-7. doi: 10.1016/j.vaccine.2007.11.061. Epub 2007 Dec 17.

HIV vaccines. Viral envelope fails to deliver?

Nature. 1998 Feb 12;391(6668):638-9. doi: 10.1038/35504.

Vaccine passes another test.

AIDS Patient Care STDS. 2001 Jul;15(7):404.

引用本文的文献

Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1).

Ther Adv Vaccines. 2013 Jul;1(2):67-80. doi: 10.1177/2051013613494534.

HIV-1 neutralizing antibodies: understanding nature's pathways.

Immunol Rev. 2013 Jul;254(1):225-44. doi: 10.1111/imr.12075.

Current progress in the development of a prophylactic vaccine for HIV-1.

Drug Des Devel Ther. 2010 Dec 22;5:9-26. doi: 10.2147/DDDT.S6959.

Induction of immunity to human immunodeficiency virus type-1 by vaccination.

Immunity. 2010 Oct 29;33(4):542-54. doi: 10.1016/j.immuni.2010.09.011.

HIV neutralizing antibodies: clinical correlates and implications for vaccines.

J Infect Dis. 2010 Apr 1;201(7):981-3. doi: 10.1086/651143.

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses.

PLoS One. 2010 Feb 2;5(2):e9015. doi: 10.1371/journal.pone.0009015.

A strategy for eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein.

PLoS One. 2010 Jan 5;5(1):e8555. doi: 10.1371/journal.pone.0008555.

Ethnic differences in the adaptation rate of HIV gp120 from a vaccine trial.

Retrovirology. 2009 Jul 15;6:67. doi: 10.1186/1742-4690-6-67.

Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies.

J Virol. 2009 Jan;83(1):188-99. doi: 10.1128/JVI.01583-08. Epub 2008 Oct 15.

A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptide.

Virology. 2008 Nov 25;381(2):241-50. doi: 10.1016/j.virol.2008.08.039. Epub 2008 Oct 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验